Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| General Motors CoGM · Entity 2958 | Director | December 31, 2025 | January 05, 2026 |
| LENZ Therapeutics, Inc.GRPH · Entity 6475 | Director | July 19, 2023 | July 21, 2023 |
| PROCTER & GAMBLE CoPG · Entity 2814 | Director | October 13, 2026 | October 14, 2026 |
| Quantinuum Inc.QNT · Entity 3437 | Director | June 04, 2026 | June 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
General Motors Co
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share Units ("DSUs")SEC Table II · derivative / convertible security | Direct | 89,247 |
Reported balance
After 2025-12-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-31 · Grant · Acquired 6,172 · Balance 89,247 F1: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. |
| Deferred Share Units ("DSUs")SEC Table II · derivative / convertible security | Direct | 90,111 |
Reported balance
After 2025-12-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-31 · Grant · Acquired 864 · Balance 90,111 F2: Represents dividends accrued on DSUs in 2025 that were credited as additional DSUs at the end of the year. F1: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. |
Filing footnotes · ownership attribution and instrument terms
F1: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.
F2: Represents dividends accrued on DSUs in 2025 that were credited as additional DSUs at the end of the year.
LENZ Therapeutics, Inc.
Report date July 19, 2023 · Filed July 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.72 · Expires 2033-07-18 | Direct | 20,000 |
Reported balance
After 2023-07-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-07-19 · Grant · Acquired 20,000 · Balance 20,000 F1: The shares subject to such option vest in full on the earlier of (i) the one-year anniversary of the grant date or on (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to such option vest in full on the earlier of (i) the one-year anniversary of the grant date or on (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.
PROCTER & GAMBLE Co
Report date October 13, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,967.634 |
Reported balance
After 2026-10-13 transaction · row 1
1 source rowRow 1 · 2026-10-13 · Grant · Acquired 1,438 · Balance 38,967.634 F1: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
Quantinuum Inc.
Report date June 04, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 72,498 |
Ending reported balance
After 2026-06-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-04 · Grant · Acquired 5,833 · Balance 5,833 F1: Represents an award of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock. The RSUs will vest in three equal annual installments beginning on June 5, 2027. Row 2 · 2026-06-05 · Purchase · Acquired 66,665 · Balance 72,498 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock. The RSUs will vest in three equal annual installments beginning on June 5, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Century Therapeutics, Inc.
Report date June 12, 2025 · Filed June 16, 2025
Section 16 reporting ended · disclosed 2021-06-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.60 · Expires 2035-06-12 | Direct | 44,000 |
Reported balance
After 2025-06-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-06-12 · Grant · Acquired 44,000 · Balance 44,000 F1: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2021 Filed Mar 10, 2021 19:00 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010023 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,524.194 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| January 14, 2021 Filed Jul 1, 2021 23:00 UTC | LENZ Therapeutics, Inc. GRPH · Entity 6475 | Exercise / conversionStock Option (right to buy) · Derivative | 49,876 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0000899243-21-027013 · doc4.xml · derivative · entry 4 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,876 shares Expires 2031-01-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. F1 · kind: This transaction occurred prior to the Issuer's initial public offering ("IPO") and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3. F2 · shares: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. F3 · derivative.exercise_date: 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of June 24, 2020, subject to the Reporting Person's continuous service to the Issuer on each such date. The option provides for an early exercise provision of unvested shares, subject to the Issuer's right to repurchase. F2 · derivative.underlying_shares: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. Read SEC document |
| January 14, 2021 Filed Jul 1, 2021 23:00 UTC | LENZ Therapeutics, Inc. GRPH · Entity 6475 | Exercise / conversionCommon Stock | 49,876 | $0.30 | $14,962.80 |
DisclosureSEC source: 0000899243-21-027013 · doc4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,815 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction occurred prior to the Issuer's initial public offering ("IPO") and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3. F2 · shares: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. F2 · price: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. F2 · balance_after: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. Read SEC document |
| January 13, 2021 Filed Jul 1, 2021 23:00 UTC | LENZ Therapeutics, Inc. GRPH · Entity 6475 | GrantStock Option (right to buy) · Derivative | 49,876 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0000899243-21-027013 · doc4.xml · derivative · entry 3 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,876 Underlying: Common Stock · 49,876 shares Expires 2031-01-12 F2 · derivative.exercise_price: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. F1 · kind: This transaction occurred prior to the Issuer's initial public offering ("IPO") and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3. F2 · shares: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. F3 · derivative.exercise_date: 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of June 24, 2020, subject to the Reporting Person's continuous service to the Issuer on each such date. The option provides for an early exercise provision of unvested shares, subject to the Issuer's right to repurchase. F2 · derivative.underlying_shares: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. F2 · balance_after: On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 21:44 UTC | General Motors Co GM · Entity 2958 | GrantDeferred Share Units · Derivative | 866 | $18.32 | $15,865.12 |
DisclosureSEC source: 0001467858-21-000010 · wf-form4_160988307845413.xml · derivative · entry 2 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,863 Underlying: Common Stock · 866 shares Expires not disclosed F4 · security: Represents dividends accrued on DSUs in 2020 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. F2 · derivative.exercise_price: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. F5 · price: The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable dividend payment date. F2 · derivative.exercise_date: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. F2 · derivative.expiration_date: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 21:44 UTC | General Motors Co GM · Entity 2958 | GrantDeferred Share Units · Derivative | 9,678 | $30.48 | $294,985.44 |
DisclosureSEC source: 0001467858-21-000010 · wf-form4_160988307845413.xml · derivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,997 Underlying: Common Stock · 9,678 shares Expires not disclosed F1 · security: Deferred Share Units ("DSUs") were awarded pursuant to the General Motors Company Deferred Compensation Plan for Non-Employee Directors (the "Plan"). Under the Plan, each non-employee director is required to defer one-half of the $305,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. F2 · derivative.exercise_price: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. F3 · price: The price of the DSUs is the average closing price of the Company's Common Stock during the previous calendar year. F2 · derivative.exercise_date: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. F2 · derivative.expiration_date: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 20:31 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 254 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030977 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,231.878 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 18:49 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 1,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026895 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,931.091 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| September 08, 2020 Filed Sep 9, 2020 18:58 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 258 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-024822 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,544.091 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 19:44 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 296 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019339 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,246.442 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 17:37 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 249 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-010388 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,905.563 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:56 UTC | General Motors Co GM · Entity 2958 | GrantDeferred Share Units · Derivative | 1,451 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001467858-20-000012 · wf-form4_157808858095475.xml · derivative · entry 2 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,319 Underlying: Common Stock · 1,451 shares Expires not disclosed F2 · derivative.exercise_price: Represents dividends accrued on DSUs in 2019 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date. F2 · price: Represents dividends accrued on DSUs in 2019 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date. F2 · derivative.exercise_date: Represents dividends accrued on DSUs in 2019 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date. F2 · derivative.expiration_date: Represents dividends accrued on DSUs in 2019 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:56 UTC | General Motors Co GM · Entity 2958 | GrantDeferred Share Units · Derivative | 7,987 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001467858-20-000012 · wf-form4_157808858095475.xml · derivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,868 Underlying: Common Stock · 7,987 shares Expires not disclosed F1 · derivative.exercise_price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2019, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.56 in 2019. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. F1 · price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2019, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.56 in 2019. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. F1 · derivative.exercise_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2019, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.56 in 2019. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. F1 · derivative.expiration_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2019, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.56 in 2019. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 15:20 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 388 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-034860 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,619.999 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 08, 2019 Filed Oct 10, 2019 20:30 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 1,654 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030375 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,196.533 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| September 10, 2019 Filed Sep 11, 2019 18:35 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 261 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-028184 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,542.533 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| June 11, 2019 Filed Jun 12, 2019 18:49 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 252 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-021451 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,257.43 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 15:16 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 225 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-011309 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,980.773 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 22:33 UTC | General Motors Co GM · Entity 2958 | GrantDeferred Share Units · Derivative | 1,095 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001467858-19-000021 · wf-form4_154655480436025.xml · derivative · entry 2 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,881 Underlying: Common Stock · 1,095 shares Expires not disclosed F2 · derivative.exercise_price: Represents dividends accrued on DSUs in 2018 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date. F2 · price: Represents dividends accrued on DSUs in 2018 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date. F2 · derivative.exercise_date: Represents dividends accrued on DSUs in 2018 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date. F2 · derivative.expiration_date: Represents dividends accrued on DSUs in 2018 that were credited as additional DSUs at the end of the year pursuant to the terms of the Plan. The dividends were converted to DSUs based on the average of the high and low trading price of the Company's Common Stock on the applicable quarterly dividend payment date. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 22:33 UTC | General Motors Co GM · Entity 2958 | GrantDeferred Share Units · Derivative | 7,538 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001467858-19-000021 · wf-form4_154655480436025.xml · derivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,786 Underlying: Common Stock · 7,538 shares Expires not disclosed F1 · derivative.exercise_price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2018, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.81 in 2018. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. F1 · price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2018, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.81 in 2018. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. F1 · derivative.exercise_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2018, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.81 in 2018. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. F1 · derivative.expiration_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2018, pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The deferred portion of the retainer fee is converted to DSUs based on the average closing price of the Company's Common Stock during the previous calendar year, which was $37.81 in 2018. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment. Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 19:19 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 293 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-036043 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,732.061 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 09, 2018 Filed Oct 11, 2018 18:15 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 2,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-029972 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,416.401 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan. Read SEC document |
| September 11, 2018 Filed Sep 12, 2018 18:44 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 336 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-027393 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,287.401 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 17:26 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 357 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-020864 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,947.189 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2014 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:03 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 121 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-011587 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,589 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 23:40 UTC | General Motors Co GM · Entity 2958 | GrantDeferred Share Units · Derivative | 726 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001467858-18-000007 · wf-form4_151502281015541.xml · derivative · entry 2 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,248 Underlying: Common Stock · 726 shares Expires not disclosed F1 · derivative.exercise_price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2017 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $37.61. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment. F1 · price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2017 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $37.61. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment. F2 · derivative.exercise_date: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year. F2 · derivative.expiration_date: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 23:40 UTC | General Motors Co GM · Entity 2958 | GrantDeferred Share Units · Derivative | 7,578 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001467858-18-000007 · wf-form4_151502281015541.xml · derivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,522 Underlying: Common Stock · 7,578 shares Expires not disclosed F1 · derivative.exercise_price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2017 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $37.61. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment. F1 · price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2017 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $37.61. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment. F1 · derivative.exercise_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2017 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $37.61. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment. F1 · derivative.expiration_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2017 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $285,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $37.61. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment. Read SEC document |
| December 31, 2016 Filed Jan 5, 2017 00:18 UTC | General Motors Co GM · Entity 2958 | GrantDeferred Share Units · Derivative | 454 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001467858-17-000017 · wf-form4_148357548159237.xml · derivative · entry 2 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,944 Underlying: Common Stock · 454 shares Expires not disclosed F2 · security: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year. F2 · derivative.exercise_price: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year. F2 · price: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year. F2 · derivative.exercise_date: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year. F2 · derivative.expiration_date: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year. Read SEC document |
| December 31, 2016 Filed Jan 5, 2017 00:18 UTC | General Motors Co GM · Entity 2958 | GrantDeferred Share Units · Derivative | 7,980 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001467858-17-000017 · wf-form4_148357548159237.xml · derivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,490 Underlying: Common Stock · 7,980 shares Expires not disclosed F1 · security: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2016 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $250,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $31.33. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment. F1 · derivative.exercise_price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2016 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $250,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $31.33. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment. F1 · price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2016 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $250,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $31.33. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment. F1 · derivative.exercise_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2016 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $250,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $31.33. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment. F1 · derivative.expiration_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2016 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $250,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $31.33. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.